MORGAN MCGINN: Open Payments
NPI 1427535574 · WAUKEE, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,718 in 124 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $2,730 · 2025 $2,718
Food & beverage: $2,463Consulting: $200Education: $55
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 18 | $432 |
| Novartis Pharmaceuticals Corporation | 14 | $404 |
| ABBVIE INC. | 18 | $385 |
| Janssen Biotech, Inc. | 14 | $301 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 9 | $290 |
| Regeneron Healthcare Solutions, Inc. | 4 | $165 |
| Arcutis Biotherapeutics, Inc. | 12 | $152 |
| Lilly USA, LLC | 6 | $149 |
| GENZYME CORPORATION | 5 | $104 |
| Organon LLC | 12 | $89 |
Products named: Bimzelx, TREMFYA, ILUMYA, RINVOQ, DUPIXENT, Rhapsido, Zoryve, SKYRIZI.
Industry payments across IA — which companies pay providers there.
